Novartis AG (NVS)
103.84
+0.74
(+0.72%)
USD |
NYSE |
Nov 21, 16:00
103.80
-0.04
(-0.03%)
After-Hours: 20:00
Novartis Market Cap: 207.59B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 206.10B |
| November 19, 2024 | 206.46B |
| November 18, 2024 | 206.00B |
| November 15, 2024 | 206.04B |
| November 14, 2024 | 206.72B |
| November 13, 2024 | 207.64B |
| November 12, 2024 | 209.76B |
| November 11, 2024 | 211.26B |
| November 08, 2024 | 212.82B |
| November 07, 2024 | 214.08B |
| November 06, 2024 | 213.54B |
| November 05, 2024 | 218.68B |
| November 04, 2024 | 220.96B |
| November 01, 2024 | 218.62B |
| October 31, 2024 | 216.72B |
| October 30, 2024 | 219.74B |
| October 29, 2024 | 220.98B |
| October 28, 2024 | 231.18B |
| October 25, 2024 | 227.50B |
| October 24, 2024 | 226.18B |
| October 23, 2024 | 228.06B |
| October 22, 2024 | 228.56B |
| October 21, 2024 | 231.38B |
| October 18, 2024 | 234.27B |
| October 17, 2024 | 232.93B |
| Date | Value |
|---|---|
| October 16, 2024 | 233.05B |
| October 15, 2024 | 232.36B |
| October 14, 2024 | 232.52B |
| October 11, 2024 | 232.36B |
| October 10, 2024 | 229.54B |
| October 09, 2024 | 231.20B |
| October 08, 2024 | 227.46B |
| October 07, 2024 | 227.64B |
| October 04, 2024 | 227.82B |
| October 03, 2024 | 227.46B |
| October 02, 2024 | 228.86B |
| October 01, 2024 | 229.02B |
| September 30, 2024 | 229.96B |
| September 27, 2024 | 234.06B |
| September 26, 2024 | 234.06B |
| September 25, 2024 | 235.72B |
| September 24, 2024 | 235.70B |
| September 23, 2024 | 235.60B |
| September 20, 2024 | 234.73B |
| September 19, 2024 | 234.81B |
| September 18, 2024 | 234.79B |
| September 17, 2024 | 234.24B |
| September 16, 2024 | 236.77B |
| September 13, 2024 | 234.16B |
| September 12, 2024 | 234.28B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
151.47B
Minimum
Mar 23 2020
244.75B
Maximum
Aug 30 2024
191.86B
Average
190.52B
Median
Market Cap Benchmarks
| AstraZeneca PLC | 199.21B |
| Johnson & Johnson | 374.39B |
| Eli Lilly and Co | 711.90B |
| Novo Nordisk AS | 456.05B |
| Monte Rosa Therapeutics Inc | 514.84M |
Market Cap Related Metrics
| PE Ratio | 12.17 |
| PS Ratio | 4.264 |
| PEG Ratio | 0.0942 |
| Price to Book Value | 4.792 |
| Price to Free Cash Flow | 17.03 |
| Price | 103.84 |
| Earnings Yield | 8.21% |
| PEGY Ratio | 0.0916 |
| Operating PE Ratio | 15.66 |
| Normalized PE Ratio | 18.09 |